相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Activatable polymer nanoagonist for second near-infrared photothermal immunotherapy of cancer
Yuyan Jiang et al.
NATURE COMMUNICATIONS (2021)
Second near-infrared photothermal materials for combinational nanotheranostics
Cheng Xu et al.
CHEMICAL SOCIETY REVIEWS (2021)
Artemisinin compounds sensitize cancer cells to ferroptosis by regulating iron homeostasis
Guo-Qing Chen et al.
CELL DEATH AND DIFFERENTIATION (2020)
Semiconducting Polycomplex Nanoparticles for Photothermal Ferrotherapy of Cancer
Shasha He et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2020)
Dihydroartemisinin initiates ferroptosis in glioblastoma through GPX4 inhibition
Renxin Yi et al.
BIOSCIENCE REPORTS (2020)
Immunostimulatory nanomedicines synergize with checkpoint blockade immunotherapy to eradicate colorectal tumors
Xiaopin Duan et al.
NATURE COMMUNICATIONS (2019)
Recent Progress in Ferroptosis Inducers for Cancer Therapy
Chen Liang et al.
ADVANCED MATERIALS (2019)
P53-dependent induction of ferroptosis is required for artemether to alleviate carbon tetrachloride-induced liver fibrosis and hepatic stellate cell activation
Ling Wang et al.
IUBMB LIFE (2019)
Hydrogen Peroxide Responsive Iron-Based Nanoplatform for Multimodal Imaging-Guided Cancer Therapy
Peng Wang et al.
SMALL (2019)
A Dual-Bioresponsive Drug-Delivery Depot for Combination of Epigenetic Modulation and Immune Checkpoint Blockade
Huitong Ruan et al.
ADVANCED MATERIALS (2019)
Emerging Strategies of Cancer Therapy Based on Ferroptosis
Zheyu Shen et al.
ADVANCED MATERIALS (2018)
Design, synthesis, cytotoxicity and mechanism of novel dihydroartemisinin-coumarin hybrids as potential anti-cancer agents
Haonan Yu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
CAR T cell immunotherapy for human cancer
Carl H. June et al.
SCIENCE (2018)
Cancer immunotherapy using checkpoint blockade
Antoni Ribas et al.
SCIENCE (2018)
Inhibiting the system x(C)over-bar/glutathione axis selectively targets cancers with mutant-p53 accumulation
David S. Liu et al.
NATURE COMMUNICATIONS (2017)
Population pharmacokinetics and electrocardiographic effects of dihydroartemisinin-piperaquine in healthy volunteers
Palang Chotsiri et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2017)
Nanomaterials for cancer immunotherapy
Wantong Song et al.
BIOMATERIALS (2017)
A melanin-mediated cancer immunotherapy patch
Yanqi Ye et al.
SCIENCE IMMUNOLOGY (2017)
Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease
Brent R. Stockwell et al.
CELL (2017)
Activatable Singlet Oxygen Generation from Lipid Hydroperoxide Nanoparticles for Cancer Therapy
Zijian Zhou et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2017)
Photodynamic Therapy Mediated by Nontoxic Core-Shell Nanoparticles Synergizes with Immune Checkpoint Blockade To Elicit Antitumor Immunity and Antimetastatic Effect on Breast Cancer
Xiaopin Duan et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2016)
PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
Weiping Zou et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Ferroptosis as a p53-mediated activity during tumour suppression
Le Jiang et al.
NATURE (2015)
The future of immune checkpoint therapy
Padmanee Sharma et al.
SCIENCE (2015)
Adaptive Immune Resistance: How Cancer Protects from Immune Attack
Antoni Ribas
CANCER DISCOVERY (2015)
Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
Roy S. Herbst et al.
NATURE (2014)
PD-1 blockade induces responses by inhibiting adaptive immune resistance
Paul C. Tumeh et al.
NATURE (2014)
Dihydroartemisinin is a hypoxia-active anti-cancer drug in colorectal carcinoma cells
Teona Ontikatze et al.
FRONTIERS IN ONCOLOGY (2014)
Prevalence of iron deficiency across different tumors and its association with poor performance status, disease status and anemia
H. Ludwig et al.
ANNALS OF ONCOLOGY (2013)
Immunogenic Cell Death in Cancer Therapy
Guido Kroemer et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
Cancer immunotherapy strategies based on overcoming barriers within the tumor microenvironment
Thomas F. Gajewski et al.
CURRENT OPINION IN IMMUNOLOGY (2013)
Physicochemical Characteristics of Nanoparticles Affect Circulation, Biodistribution, Cellular Internalization, and Trafficking
Xiaopin Duan et al.
SMALL (2013)
Iron and cancer: more ore to be mined
Suzy V. Torti et al.
NATURE REVIEWS CANCER (2013)
Artesunate/dihydroartemisinin pharmacokinetics in acute falciparum malaria in pregnancy: absorption, bioavailability, disposition and disease effects
Rose McGready et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Scott J. Dixon et al.
CELL (2012)
Immunogenic cell death and DAMPs in cancer therapy
Dmitri V. Krysko et al.
NATURE REVIEWS CANCER (2012)
Review of the clinical pharmacokinetics of artesunate and its active metabolite dihydroartemisinin following intravenous, intramuscular, oral or rectal administration
Carrie A. Morris et al.
MALARIA JOURNAL (2011)
Mitochondria in innate immune responses
A. Phillip West et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Calreticulin Is the Dominant Pro-Phagocytic Signal on Multiple Human Cancers and Is Counterbalanced by CD47
Mark P. Chao et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Immunogenic and tolerogenic cell death
Douglas R. Green et al.
NATURE REVIEWS IMMUNOLOGY (2009)
gamma-H2AX in recognition and signaling of DNA double-strand breaks in the context of chromatin
Andrea Kinner et al.
NUCLEIC ACIDS RESEARCH (2008)
Qinghaosu (Artemisinin): The price of success
N. J. White
SCIENCE (2008)
Evidence for the involvement of carbon-centered radicals in the induction of apoptotic cell death by artemisinin compounds
Amy E. Mercer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Calreticulin exposure dictates the immunogenicity of cancer cell death
Michel Obeid et al.
NATURE MEDICINE (2007)
Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison
Frank Smithuis et al.
LANCET (2006)
Dihydroartemisinin is cytotoxic to papillomavirus-expressing epithelial cells in vitro and in vivo
GL Disbrow et al.
CANCER RESEARCH (2005)
The key role of heme to trigger the antimalarial activity of trioxanes
A Robert et al.
COORDINATION CHEMISTRY REVIEWS (2005)
分享论文
